000 | 01134 a2200289 4500 | ||
---|---|---|---|
005 | 20250513230003.0 | ||
264 | 0 | _c20010301 | |
008 | 200103s 0 0 eng d | ||
022 | _a1027-3719 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMurthy, K J | |
245 | 0 | 0 |
_aUse of oral salbutamol in improving quality sputum microscopy in the DOTS strategy. _h[electronic resource] |
260 |
_bThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _cDec 2000 |
||
300 |
_a1191-2 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 | _aAdrenergic beta-Agonists |
650 | 0 | 4 | _aAlbuterol |
650 | 0 | 4 |
_aDrug Monitoring _xmethods |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aSputum _xmicrobiology |
650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
700 | 1 | _aYazdani, A | |
700 | 1 | _aLakshmi, K A | |
773 | 0 |
_tThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _gvol. 4 _gno. 12 _gp. 1191-2 |
|
999 |
_c11084487 _d11084487 |